1)McQuarrie I, et al:Effects of excessive ingestion of sodium and potassium salts on carbohydrate metabolism and blood pressure in diabetic children;Nine figures. The Journal of Nutrition 11:77-101, 1936
2)佐々木直亮,他:東北地方の中年者の血圧と2, 3の生活条件との関係について.弘前医学15:368-375, 1963
3)Meneely GR, Battarbee HD:Sodium and potassium. Nutr Rev 34:225-235, 1976
4)Mente A, et al:Association of urinary sodium and potassium excretion with blood pressure. N Engl J Med 371:601-611, 2014
5)Miller V, et al:Fruit, vegetable, and legume intake, and cardiovascular disease and deaths in 18 countries(PURE);A prospective cohort study. Lancet 390:2037-2049, 2017
6)Ellison DH, et al:Potassium and its discontents;New insight, new treatments. J Am Soc Nephrol 27:981-989, 2016
and the renin-angiotensin-aldosterone system;New insights into their role in blood pressure control and hypertension treatment. J Physiol 597:4451-4464, 2019
8)Ishizawa K, et al:Calcineurin dephosphorylates Kelch-like 3, reversing phosphorylation by angiotensin Ⅱ and regulating renal electrolyte handling. Proc Natl Acad Sci U S A 116:3155-3160, 2019
9)Shibata S, et al:Angiotensin Ⅱ signaling via protein kinase C phosphorylates Kelch-like 3, preventing WNK4 degradation. Proc Natl Acad Sci U S A 111:15556-15561, 2014
10)Wall SM, et al:The renal physiology of pendrin-positive intercalated cells. Physiol Rev 100:1119-1147, 2020
11)Bakris GL, et al:Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes. N Engl J Med 383:2219-2229, 2020
12)Ando K, et al:Anti-albuminuric effect of the aldosterone blocker eplerenone in non-diabetic hypertensive patients with albuminuria;A double-blind, randomised, placebo-controlled trial. Lancet Diabetes Endocrinol 2:944-953, 2014
13)Kleinewietfeld M, et al:Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature 496:518-522, 2013